Clinical improvement in cystic fibrosis following anti-tumourous chemotherapy.

Clinical improvement in cystic fibrosis following anti-tumourous chemotherapy.

Opis bibliograficzny
Główni autorzy:	Eisen, S, Painter, H, Hyde, S, Davies, J, Jaffé, A
Format:	Journal article
Język:	English
Wydane:	2004

Podobne zapisy

Exploring the mechanisms of macrolides in cystic fibrosis.
od: Equi, A, i wsp.
Wydane: (2006)

Gene therapy for cystic fibrosis: from basic research to clinical impact
od: Hyde, S
Wydane: (2013)

Emerging gene therapies for cystic fibrosis
od: Miah, K, i wsp.
Wydane: (2019)

Aerosol delivery of DNA/liposomes to the lung for cystic fibrosis gene therapy.
od: Davies, L, i wsp.
Wydane: (2014)

Non-viral CFTR gene delivery to the lungs of Cystic Fibrosis patients
od: Hyde, S
Wydane: (2013)

Gut Bifidobacteria enrichment following oral Lactobacillus-supplementation is associated with clinical improvements in children with cystic fibrosis
od: Kathryn J. Ray, i wsp.
Wydane: (2022-07-01)

Longitudinal improvements in clinical and functional outcomes following initiation of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis
od: Kadambari Vijaykumar, i wsp.
Wydane: (2024-04-01)

Towards gene therapy for cystic fibrosis: Biodistribution of GL67A/pGM169 DNA and mRNA following aerosol delivery to the mouse lung
od: Pringle, I, i wsp.
Wydane: (2008)

A poly-functional gene delivery system for cystic fibrosis
od: Montier, T, i wsp.
Wydane: (2017)

Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung.
od: McLachlan, G, i wsp.
Wydane: (2011)

Computed tomography body composition and clinical outcomes following lung transplantation in cystic fibrosis
od: Ann L Jennerich, i wsp.
Wydane: (2023-03-01)

Gene therapy for the treatment of cystic fibrosis
od: Burney TJ, i wsp.
Wydane: (2012-05-01)

Future therapies for cystic fibrosis
od: Lucy Allen, i wsp.
Wydane: (2023-02-01)

Tromethamine improves mucociliary clearance in cystic fibrosis pigs
od: Jamison J. Ash, i wsp.
Wydane: (2022-09-01)

Malassezia Folliculitis following Triple Therapy for Cystic Fibrosis
od: Federica Li Pomi, i wsp.
Wydane: (2022-09-01)

Update of Faecal Markers of Inflammation in Children with Cystic Fibrosis
od: Jung M. Lee, i wsp.
Wydane: (2012-01-01)

Preparation for a first-in-man lentivirus trial in cystic fibrosis patients
od: Griesenbach, U, i wsp.
Wydane: (2016)

CpG-free plasmid expression cassettes for cystic fibrosis gene therapy
od: Pringle, I, i wsp.
Wydane: (2012)

CpG-free plasmid expression cassettes for cystic fibrosis gene therapy.
od: Pringle, I, i wsp.
Wydane: (2012)

Cystic fibrosis
od: Radlović Nedeljko
Wydane: (2012-01-01)

Strategies for care quality improvement in Cystic Fibrosis
od: Gilles Rault, i wsp.
Wydane: (2018-02-01)

TLR5 as an anti-inflammatory target and modifier gene in cystic fibrosis.
od: Blohmke, C, i wsp.
Wydane: (2010)

Cystic fibrosis transmembrane conductance regulator (CFTR)-targeted therapeutics for cystic fibrosis
od: Veselu, D-F, i wsp.
Wydane: (2024)

Autoimmunity in cystic fibrosis: significance and clinical implications
od: Kenneth Iwuji, i wsp.
Wydane: (2018-04-01)

A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis
od: Alton, E, i wsp.
Wydane: (2013)

A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis.
od: Alton, E, i wsp.
Wydane: (2013)

Obesity in cystic fibrosis
od: Katherine A. Kutney, i wsp.
Wydane: (2021-12-01)

Comparative microbiome analysis in cystic fibrosis and non-cystic fibrosis bronchiectasis.
od: Heryk Motta, i wsp.
Wydane: (2024-05-01)

Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis
od: Giuseppe Fabio Parisi, i wsp.
Wydane: (2022-05-01)

Non-viral vectors in cystic fibrosis gene therapy: recent developments and future prospects.
od: Pringle, I, i wsp.
Wydane: (2009)

Glycosaminoglycans as Multifunctional Anti-Elastase and Anti-Inflammatory Drugs in Cystic Fibrosis Lung Disease
od: Judith A. Voynow, i wsp.
Wydane: (2020-07-01)

Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis
od: Bergin DA, i wsp.
Wydane: (2013-01-01)

Cystic Fibrosis in Malaysian Children
od: Norzila, M.Z., i wsp.
Wydane: (2005)

Multidimensional clinical phenotyping of an adult cystic fibrosis patient population.
od: Douglas J Conrad, i wsp.
Wydane: (2015-01-01)

Inflammation in Cystic Fibrosis
Wydane: (1996-01-01)

Vasculitis in Cystic Fibrosis
od: Francesca Sposito, i wsp.
Wydane: (2020-11-01)

Pulmonology: Cystic Fibrosis
od: María GARCÍA MORO, i wsp.
Wydane: (2016-04-01)

Telemedicine in cystic fibrosis
od: Marisa E. Desimone, i wsp.
Wydane: (2021-12-01)

Clinical impact of Achromobacter xylosoxidans colonization/infection in patients with cystic fibrosis
od: M.C. Firmida, i wsp.
Wydane: (2016-01-01)

Cystic fibrosis - Ways to improve the quality of life of patients
od: Kamila Świercz, i wsp.
Wydane: (2023-04-01)